High NFS1 expression was revealed in multiple tumor tissues and indicated poor survival and poor response to chemotherapy in patients with CRC, which suggested that NFS1 may be a widespread potential prognostic indicator for patients with tumor. The gene discussed is NFS1; the disease is neoplasm.